These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 872292

  • 1. The rabbit as an animal model for the activated factor X-antithrombin III-heparin reaction.
    Gitel SN, Wessler S, Medina VM.
    Circ Res; 1977 Aug; 41(2):187-91. PubMed ID: 872292
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR, Lie M, Abildgaard U.
    Haemostasis; 1976 Aug; 5(5):265-75. PubMed ID: 1017722
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
    Ellis V, Scully MF, Kakkar VV.
    Biochem J; 1986 Sep 01; 238(2):329-33. PubMed ID: 3800942
    [Abstract] [Full Text] [Related]

  • 8. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G, Blaskó G, Bánhegyi D, Jákó J, Pálos LA.
    Thromb Diath Haemorrh; 1974 Sep 30; 32(1):105-15. PubMed ID: 4454033
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):748-62. PubMed ID: 1209544
    [Abstract] [Full Text] [Related]

  • 12. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M, Holmer E, de Mol M, Collen D.
    Thromb Haemost; 1983 Apr 28; 49(2):109-15. PubMed ID: 6868006
    [Abstract] [Full Text] [Related]

  • 13. Plasma antithrombin III: a quantitative assay of biological activity.
    Gitel SA, Wessler S.
    Thromb Res; 1975 Jul 28; 7(1):5-16. PubMed ID: 1154342
    [No Abstract] [Full Text] [Related]

  • 14. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
    Ototani N, Kikuchi M, Yosizawa Z.
    Biochem J; 1982 Jul 01; 205(1):23-30. PubMed ID: 7126178
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of continuous low-dose intravenous heparin administered during operation on postoperative measurements of antithrombin III and antifactor Xa.
    Jennings SA, Heather BP, Greenhalgh RM.
    Surgery; 1984 Sep 01; 96(3):550-5. PubMed ID: 6474360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E, Vigo A, Pogliani EM.
    Thromb Haemost; 1981 Dec 23; 46(4):749-51. PubMed ID: 6460339
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antithrombin 3, antifactor Xa and heparin.
    Biggs R, Denson KW, Akman N, Borrett R, Hadden M.
    Br J Haematol; 1970 Sep 23; 19(3):283-305. PubMed ID: 5529547
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.